Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Erosive pustular dermatosis of the scalp induced by ingenol mebutate.

Brambilla L, Tourlaki A, Nazzaro G.

G Ital Dermatol Venereol. 2018 Oct;153(5):743-745. doi: 10.23736/S0392-0488.17.05691-7. Epub 2017 Sep 8. No abstract available.

PMID:
28895376
2.

Erosive pustular dermatosis of the scalp following topical ingenol mebutate for actinic keratoses.

Vaccaro M, Borgia F, Gasco L, Cannavò SP.

Dermatol Ther. 2017 Sep;30(5). doi: 10.1111/dth.12521. Epub 2017 Jul 7. No abstract available.

PMID:
28685901
3.

Erosive pustular dermatosis of the scalp after photodynamic therapy.

López V, López I, Ramos V, Ricart JM.

Dermatol Online J. 2012 Sep 15;18(9):13.

4.

[Bullous reaction after application of a single dose ingenol mebutate].

Salskov-Iversen ML, Lorentzen HF.

Ugeskr Laeger. 2013 Dec 2;175(49A):V07130437. Danish.

PMID:
25353257
5.

Ingenol mebutate gel for actinic keratosis.

Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, Berman B.

N Engl J Med. 2012 Mar 15;366(11):1010-9. doi: 10.1056/NEJMoa1111170.

6.

Erosive pustular dermatosis of the scalp following topical methylaminolaevulinate photodynamic therapy.

Guarneri C, Vaccaro M.

J Am Acad Dermatol. 2009 Mar;60(3):521-2. doi: 10.1016/j.jaad.2008.09.006. No abstract available.

PMID:
19231656
7.

Local skin reactions following the administration of topical ingenol mebutate for actinic keratosis.

Conde-Taboada A, Mercado B, Aranegui B, González-Guerra E, López-Bran E.

Dermatol Online J. 2017 Sep 15;23(9). pii: 13030/qt610558x9.

8.

Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis.

Berman B.

Expert Opin Drug Saf. 2015;14(12):1969-78. doi: 10.1517/14740338.2015.1108962. Epub 2015 Nov 2. Review.

PMID:
26524598
9.

Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp.

Stockfleth E, Harwood CA, Serra-Guillén C, Larsson T, Østerdal ML, Skov T.

Br J Dermatol. 2018 Feb;178(2):433-442. doi: 10.1111/bjd.16048. Epub 2018 Jan 15.

PMID:
29030864
10.

Ingenol mebutate: a new option for actinic keratosis treatment.

Gras J.

Drugs Today (Barc). 2013 Jan;49(1):15-22. doi: 10.1358/dot.2013.49.1.1910723. Review.

PMID:
23362492
11.

Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses.

Lebwohl M, Shumack S, Stein Gold L, Melgaard A, Larsson T, Tyring SK.

JAMA Dermatol. 2013 Jun;149(6):666-70. doi: 10.1001/jamadermatol.2013.2766.

PMID:
23553119
12.

Squamous cell carcinoma developed after ingenol mebutate therapy: a possible consequence of the treatment?

Maglie R, Grandi V, Maio V, Pileri A.

G Ital Dermatol Venereol. 2018 Jun;153(3):442-443. doi: 10.23736/S0392-0488.17.05564-X. No abstract available.

PMID:
29766707
13.

Clinical and Histologic Evaluation of Ingenol Mebutate 0.015% Gel for the Cosmetic Improvement of Photoaged Skin.

Handler MZ, Bloom BS, Goldberg DJ.

Dermatol Surg. 2018 Jan;44(1):61-67. doi: 10.1097/DSS.0000000000001269.

PMID:
28858927
14.
15.

PICATO (ingenol mebutate 0.015% and 0.05% gels): a novel treatment for actinic keratosis.

Abramovits W, Oquendo M, Vincent KD, Gupta AK.

Skinmed. 2013 Mar-Apr;11(2):111-5. No abstract available.

PMID:
23745230
16.
17.

Two cases of erosive pustular dermatosis of the scalp occurring after topical 3.75% imiquimod for actinic keratoses.

Giuffrida R, Borgia F, Cannavò SP.

Dermatol Ther. 2019 Jan;32(1):e12770. doi: 10.1111/dth.12770. Epub 2018 Nov 18. No abstract available.

PMID:
30315627
18.

Efficacy and safety of ingenol mebutate 0.015% gel 3 weeks after cryosurgery of actinic keratosis: 11-week results.

Berman B, Goldenberg G, Hanke CW, Tyring SK, Werschler WP, Knudsen KM, Goncalves J, Larsson T, Skov T, Swanson N.

J Drugs Dermatol. 2014 Feb;13(2):154-60.

PMID:
24509965
19.

A seamless phase I/II dose-finding trial assessing ingenol disoxate (LEO 43204) for field treatment of actinic keratosis on the scalp.

Weiss J, Ulrich M, Bukhalo M, Østerdal ML, Bang B, Hanke CW.

Br J Dermatol. 2017 Jun;176(6):1456-1464. doi: 10.1111/bjd.15304. Epub 2017 Apr 25.

PMID:
28078678
20.

Improvement of erosive pustular dermatosis of the scalp following discontinuation of chemotherapy with afatinib.

Goto K, Nomura T, Kogame T, Irie H, Kaku Y, Dainichi T, Kabashima K.

Eur J Dermatol. 2018 Apr 1;28(2):258-259. doi: 10.1684/ejd.2018.3220. No abstract available.

PMID:
29400287

Supplemental Content

Support Center